Expression of Inflammatory Proteins in Pancreatic Cancer

NCT00551057 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2010-09-17

No results posted yet for this study

Summary

The purpose of this trial is to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue.

Conditions

  • Pancreatic Neoplasms

Interventions

BEHAVIORAL

Expression type

to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Marc Schiesser, MD · UniversitaetsSpital Zuerich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Completion
2012-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00551057 on ClinicalTrials.gov